1) Strategy & Leadership - Humana's leadership expressed satisfaction with year-to-date performance and reaffirmed commitment to achieving a sustainable pretax margin of at least 3% by 2028. - The company is focused on four key drivers: product and experience, clinical excellence, operational efficiency, and growth in CenterWell and Medicaid. - New board members Paul Smith and Fred Crawford bring extensive experience in technology and finance, enhancing the board's expertise.

2) Financial & Segment Results - Humana's 2026 membership growth trajectory is on track, with expectations for continued performance. - The consolidated operating cost ratio improved by 120 basis points YoY, with a full-year reduction expected to be around 150 basis points. - Cost trends for 2026 are projected to be in the high single-digit range (7%-8%), with some favorability noted in inpatient care.

3) Operational Plans & Efficiency - The company is centralizing operations to enhance efficiency, such as consolidating utilization management across 11 markets. - Humana is expanding outsourcing in finance and HR, aiming to improve vendor performance and reduce costs. - The integration of CarePlus operations is expected to drive greater value and scale.

4) Guidance & Outlook - Humana anticipates significant progress in MA margin expansion in 2027, with adjustments to plan mix and benefits. - Approximately 600,000 members may be impacted by planned market exits, but the company aims to recapture a significant portion of that volume. - A virtual investor update is scheduled for December 10, 2026, to discuss progress on commitments and provide insights into membership expectations for 2027.

5) Problems / Headwinds - The company faces uncertainties regarding the Stars program outcomes, with the final data from CMS expected in October. - While Humana is optimistic about its operational progress, it acknowledges the inherent unknowns related to industry thresholds and competitive dynamics.

Bottom line: Humana is executing its strategy effectively, with solid membership growth and operational improvements. The company is on track to meet its long-term margin goals, although it faces challenges related to the Stars program and market dynamics. Investors should remain optimistic about the company's outlook as it prepares for significant developments in 2027.